why is compounded tirzepatide cheaper What Tirzepatide? TrimRX | Tirzepatide Cost Barriers
Description
Seguimiento de GLP-1 fcil
Current annual therapy cost: ~1.51.7 lakh per patient At 5060% lower pricing: ~70,00085,000 per year Savings of nearly 80,0001,00,000 per patient annually Now consider scale: 100,000 patients 75,000 750 crore annual market 500,000 patients (just ~0.5% of high-risk obese population) 3,750 crore opportunity And thats only drug revenue
We offer valuable treatment references for physicians.
Freezer-safe and precision-fit because your protocol demands nothing less
We offer a medically supervised weight loss program that includes the revolutionary drug semaglutide
